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It has been found that Nrisonicotinoyl-N,-3-methyl-4-chlorobenzoylhydra- 
zinc (IMCBH, see Fig. 1) inhibits the multiplication and the cytopathic effects 
of vaccinia virus in chick embryo fibroblasts and monkey kidney cells. Virus- 
inhibitory  concentrations  of  IMCBH  do  not  cause  significant  morphologic 
changes in uninfected cells. The present communication describes these findings 
and the effect of IMCBH on the multiplication cycle of vaccinia virus. Evidence 
will be presented that IMCBH  inhibits the release of vaccinia virus from the 
infected ceil. 
Materials and Methods 
Compound.--Na4sonicotinoyl-N2-3-methyl4-chlorobenzoylhydra~ne  (IMCBH)  was  syn- 
thesized  by Dr. E.  Winkelmann, Farbwerke Hoechst AG, Hoechst, Germany. IMCBH is 
difficult to dissolve in cold water but dissolves to a  limited extent in hot water. IMCBH 
suspended in Eagle's minimum essential medium (MEM) (1) at a concentration of 200/zg/ml 
was dissolved by heating of the suspension at 80°C for 1 hr. This stock solution was diluted 
further with the same medium to give the desired concentrations. 
Viruses.--Three strains of vaccinia virus (P71, MPI, and IHD) were used. The P71 strain 
was obtained from the Virological Laboratory of Farbwerke Hoechst AG, Hoechst, Germany; 
the MPI strain from Dr. H. Gerth, Hygiene-Institut, Tiibingen, Germany; the IHD strain 
(2) from Dr. S. Dales, The Public Health Research Institute of the City of New York, N.Y. 
The PT1 and MPI strains were grown in chick embryo fibroblasts.  The IHD strain, which 
had been passaged in L cells in Dr. Dales' laboratory, was grown in L cells. 
Sindbis,  vesicular  stomatitis,  Newcastle  disease  (Miyadera),  fowl  plague  (Rostock), 
polio type 1 (Mahoney), ECHO type 12  (Travis), reo type 3  (Dearing),  and adeno type 7 
virus were also tested. Sindbis and vesicular  stomatitis virus were propagated in chick embryo 
fibroblasts,  Newcastle disease  and  fowl plague virus in  embryonated eggs, and  the other 
viruses  in  monkey kidney cells. 
Cell Cultures.--Chick embryo fibroblasts were prepared from  11  day-old embryos by 
trypsinization according to Kraus and Schiffer (3). They were grown in plastic Petri dishes 
(60 X  15 ram, Greiner, Niirtingen, Germany) or in screw cap glass tubes. Dishes and loosely 
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closed tubes were incubated at 37°C in a humidified atmosphere of 5% CO2 in air. When used 
after overnight incubation, Petri dishes contained approximately 4  X  106 cells per dish. 
Tube cultures of rhesus monkey kidney, L, and BHK21 cells were also used. Rhesus monkey 
kidney cells were obtained by trypsinization. The growth medium for monkey kidney cells 
consisted of Eagle's MENI with 5% heat-inactivated fetal bovine serum, the growth medium 
for L  and BHK21  cells of reinforced Eagle's medium  (4) with  10% heat-inactivated fetal 
bovine serum. 
Eagle's MEM without serum was used as maintenance medium for all cell cultures. 
Virus  Titralgons in  Tube Cultures.--Serial  10-fold  dilutions of virus were  made  and  0.1 
ml aliquots of each dilution were inoculated into groups of three tubes containing 1.9 ml of 
maintenance medium. The cultures were incubated at 37°C  in a  stationary position. They 
were observed at least every 2nd day for the development of cytopathic effects; the final 
readings were made 5 days after virus inoculation. The amount of  infective virus was ex- 
pressed in terms of 50% tissue culture infective doses (TCID~0). 
Plaque Assay.--In  most experiments, measurement of infective virus was carried out by 
plaque assay. Plastic Petri dishes with confluent monolayer cultures of chick embryo fibro- 
blasts were incubated with 0.2  ml of serial 10-fold  dilutions of virus in Lavit medium  (3). 
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FIG.  1. Structure  of Nl-isomcotmoy]-N~-3-methyl-4-chiorohenzoylhydra~_ne. 
Two dishes per dilution were used. After an adsorption period of 1 hr at 37°C,  the cell sheet 
was overlaid with 4 ml of agar overlay. The overlay consisted of equal volumes of 1.4% agar 
and two times concentrated Lavit medium. Cultures were incubated for 4  days at 37°C  in 
5% CO2. Then, 0.5 ml of 0.05% neutral red in water was added to each culture. Plaques were 
counted 3 hr later.  1 plaque-forming unit (PFU) of vaccima virus (P71) was found to cor- 
respond  to  approximately 3  TCID~0. 
Growth Curve Ex~eriments.--Replicate  chick  embryo  cell  monolayers  in  plastic  Petri 
dishes were washed with phosphate-buffered saline (PBS)  (5) and inoculated with 0.5 ml of 
virus contained in medium with or without IMCBH. After adsorption for 2 hr at 37°C in 5% 
CO2, the inoeulum was removed, the monolayers were washed twice with warm PBS with or 
without IMCBH, 4 ml of Eagle's MEM with or without IMCBH was added, and the dishes 
were incubated at 37°C in 5% CO2. At intervals, four dishes were removed from the incubator. 
For determination of released virus, the fluid medium of two dishes was collected, centrifuged 
at 3000 rpm for 10 rain, and the superuatant Stored at --35°C until assayed. The two other 
dishes were placed at  --35°C. Subsequently, the cultures were thawed, the cell sheets were 
scraped from the plastic surface, and the cells with their supernatant medium were harvested. 
Samples were rapidly frozen and thawed three times, and centrifuged at 3000 rpm for 10 min 
to remove debris. The superuatant was stored at  --35°C until assayed. These samples were 
used for assay of the total amount of virus produced.  For determination of cell-associated 
virus, two dishes of cultures from which fluid medium had been removed were washed twice 
with YBS, 4 ml of Eagle's MEM was added to each dish, and the dishes were placed at --35°C. 
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virus. Measurement of infective virus was performed by plaque assay. The time of virus inocu- 
lation was considered zero time. 
RESULTS 
Toxidty of IMCBH to Chide Embryo Fibroblc~ts.--IMCBH did not cause any 
toxic morphologic changes in all kinds of cells used in the present study up to a 
concentration of 50 ~g/ml. The minimal concentration to cause detectable mor- 
phologic changes in chick embryo fibroblasts was 70 #g/ml. 
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FIG. 2. Lack of inhibitory effect of IMCBH on the multiplication of chick embryo fibro- 
blasts. 
The rate of multiplication of chick embryo fibroblasts was studied in the pres- 
ence or absence of IMCBH. The concentrations  of IMCBH employed were 
12.5, 25, and 50/~g/ml, which were sufficient to cause marked inhibition of virus 
release (see below). Plastic Petri dishes were seeded with 6 X  105 cells per dish 
suspended in 4 ml of growth medium with or without compound. The growth 
medium consisted of Eagle's MEM containing 10 % heat-inactivated fetal bo- 
vine serum. Two dishes were used per variable. The cultures were incubated at 
37°C in 5 % COs. At intervals, the supematant medium was removed, the cell 
sheets were washed once with PBS deficient in calcium and magnesium, and 
were trypslnlzed. The cells were suspended in appropriate volumes of PBS and 
counted in a hemocytometer. The initial ceU count was performed 14 hr after 
seeding, and all subsequent counts were expressed as a multiple of the initial 
cell count.  There was no obvious difference in the attachment of ceils to the 
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embryo fibroblasts are shown in Fig. 2. As can be seen,  IMCBH at concentra- 
tions up to 50 ~g/ml did not influence the rate of multiplication of the cells. 
Minimal Concentration of IMCBH to Inhibit  the  Multiplication  of Vaccinia 
Virus in  Various  Cell Cultures.--To  determine  the minimal  concentration of 
IMCBH to inhibit vaccinia virus multiplication,  tube cultures were infected 
with a small dose of virus and incubated in medium containing increasing con- 
centrations of IMCBH. At intervals, the cultures were examined for develop- 
ment of cytopathic effects (CPE). The experimental procedure was essentially 
TABLE I 
Minimal Concentration of IMCBH to Inhibit the Development of Cytopatkic 
Effects of Vaccinia Virus in Various Cell Cultures 
Minimal inhibitory  Cells  Virus strain*  Dose of inoculum  concentrat/on~ 
Chick  embryo fibroblasts 
Monkey kidney cells 
L cells 
BHK21 cells 
P71 
MPI 
IHD 
P71 
MPI 
IHD 
IHD 
P71 
TCID60/~be 
3,200 
320 
1,000 
3,200 
320 
1,000 
560 
630,000§ 
~,g/ml 
3.1 
25 
3.1 
6.3 
12.5 
12.5 
>100 
>  50 
* The PT1 and MPI strains were passaged in chick embryo fibroblasts. The IHD strain 
was passaged in L cells. 
:~ The lowest concentration inhibiting completely the development of CPE. 
§ Titrated in chick embryo fibroblasts. 
the same as described by Eggers and Tamm (6).  Medium was removed from 
tube cultures, to each tube 1.9 ml of Eagle's MEM with or without serial 2-fold 
concentrations of IMCBH was added, and each tube received 0.1 ml of virus. 
In each experiment,  uninfected control cultures with  or without serial  2-fold 
concentrations of the compound were set up, and infectivity titrations of the 
virus inocula were simultaneously carried out. Three tubes were used per vari- 
able. In the experiments with chick embryo fibroblasts, monkey kidney, and L 
cells, virus inocula of 300-3000 TCIDs0 were used. The cultures were incubated 
at 37°C in 5 % CO2, and examined daily or every other day for the development 
of CPE. The final reading was made 5 days after virus inoculation. The lowest 
concentration of IMCBH which completely inhibited the development of CPE 
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In the experiments with BHK21 cells, undiluted virus stock (about 6 X  1@ 
TCID,0/0.1 ml) was inoculated, the cultures were examined every hour, and the 
final readings were made 12 hr a/ter inoculation (see below). 
Typical results of these experiments are shown in Table I. As can be seen, the 
development of CPE of vaccinia virus in chick embryo fibroblasts and monkey 
kidney cells  was  completely inhibited  by  relatively low  concentrations  of 
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Fxo. 3. Lack of direct inactivating effect of IMCBH on the infectivity of vaccinia virus 
The rate of inactivation of virus at 37°C in the presence or absence of 50 ~g/ml of IMCBH 
was determined. 
IMCBH. Of the three virus strains, P71 and IHD exhibited a similar degree of 
susceptibility in these two cell types. The MPI strain was less susceptible in 
chick embryo fibroblasts than the other two strains, although it showed a similar 
susceptibility in monkey kidney ceils.  These results were consistently and re- 
producibly obtained in several experiments. 
On the other hand, the IHD strain was resistant to IMCBH in L  cells. The 
effect of IMCBH on the multiplication of the P71 and MPI strains in L  cells 
could not be examined because they do not multiply in these cells. 
The development of CPE in BHK21 cells infected with large doses of vaccinia 
virus (P71) was not prevented by IMCBH. It has been found that BHK21 cells h'~'~  *  I  I  I  I  l 
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showed definite morphologic changes 3 hr after infection with high concentra- 
tions of vaccinia virus (P71) passaged in chick embryo fibroblasts. The changes 
consisted of cell rounding, agglutination, and later cellular destruction. Almost 
all cells were affected 7 hr after infection.  These changes were not associated 
with virus multiplication. The cytopathic changes  were observed  only when 
large inocula were used, and they no longer occurred in succeeding passages in 
BHK21 ceils. These observations  point to the toxic nature of this cytopathic 
change. In addition, they are in agreement with the findings on the toxic effects 
of vaccinia virus already reported (7-13). 
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FIO. 5. Effect of IMCBH on the development  of cytopathie  effects of vaccinia  virus in 
chick embryo fibroblasts. The data are obtained from the experiment shown in Fig. 4. 
Lack of Direct Inactivating Effect of IMCBH on Vaccinia Virus.--To examine 
whether IMCBH has any direct inactivating effect on vaccinia virus, the rate of 
inactivation of vaccinia virus at 37°C in the presence or absence of 50 pg/ml of 
IMCBH was determined. To each plastic Petri dish, 4 ml of Eagle's MEM con- 
taining about 2 ×  105 PFU/ml of vaccinia virus (PT1), with or without com- 
pound, was added. The dishes were incubated at 37°C. Two dishes per variable 
were used. At intervals virus material was removed from the dishes and stored 
at -35°C until assayed by the plaque method. The results are shown in Fig. 3. 
The rate of decline of infectivity titers at 37°C was similar in the presence and 
absence of compound. Thus, IMCBH does not cause direct inactivation of vac- 
cinia virus held in contact with concentrations up to 50 #g/ml. 
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Virus During a Single Infectious Cyde.--Chick embryo fibroblast cultures were 
infected with strain P71 at an input multiplicity of 1 PFU/cell. The concentra- 
tions of IMCBH used ranged between 3.1  and 50 #g/ml,  sufficient to cause 
marked inhibition of virus multiplication under conditions of infection at low 
multiplicity (see Table I). The amount of infective virus produced,  virus re- 
lease, and virus-induced cell damage were determined.  Cells exhibiting retrac- 
tion and rounding were considered damaged. Cytopathic changes were expressed 
as per cent cells affected. The results of a typical experiment are shown in Figs. 
4 and 5. The most conspicuous finding in Fig. 4 is a  striking difference in the 
growth curves of total and released virus in IMCBH-treated cultures. The onset 
and slope of the production of total virus were closely similar in IMCBH-treated 
and untreated, control cultures. A difference was observed only after 18-21 hr; 
the growth  curves of  treated  cultures  leveled off earlier and  the amount  of 
virus produced was about 2.5-7.5 times lower than that in control cultures. 
On the other hand, the release of infective virus was markedly inhibited in 
IMCBH-treated cultures. While in control cultures the phase of logarithmic 
increase of released virus began 6 hr after virus inoculation, in treated cultures 
a  significant release of virus was first detected 21 hr postvirus inoculation. A 
steady but only very slight increase of released virus was then observed. 78 hr 
after  virus  inoculation,  the  amount  of  released  virus  in  treated  cultures 
amounted to about 0.5 to 1% of total virus produced, whereas in control cul- 
tures more than 50 % had been released. 
While cells in control cultures showed a complete CPE 36 hr after virus inoc- 
ulation, cells in treated cultures exhibited no cytopathic changes up to 42-48 hr 
postvirus inoculation (Fig. 5). Mter this time CPE developed, and most cells 
were affected 78 hr after virus inoculation. The cytopathic changes in treated 
cultures were microscopically similar to those in control cultures (cell rounding). 
It should be emphasized that these cytopathic changes in treated cultures were 
not accompanied by a significant release of virus. 
This experiment demonstrates that IMCBH blocks the release of virus from 
the cells,  while intracellular virus multiplication is only slightly affected. This 
was confirmed in a  similar type of experiment, in which total, ceil-associated, 
and released virus was assayed (Fig. 6). In treated cultures, nearly all infective 
virus remained cell-associated for at least 36 hr, the duration of this experiment. 
In control cultures, on the other hand,  the increase in the amount of released 
virus occurred at an exponential rate soon after intracellular multiplication was 
detectable. 
Effect of IMCBH Added at Various Times during a Single Cycle of Vaccinia 
Virus Multiplication.--The  following study was carried out to determine the 
effect of IMCBH  on  vaccinia virus  release  and  development of  cytopathic 
changes when added at various times during a single infectious cycle. The input 
multiplicity in  these  experiments was  1 PFU/cell,  and  the concentration  of NOBUO  KATO~ HANS  J.  EGGERS~ AND  HEINEICH ROLLY  803 
IMCBH was 25 pg,/ml. The data in Fig.  7 are from a  typical experiment in 
which IMCBH was added 2, 6, 9,  12, and 15 hr after virus inoculation. The 
addition of IMCBH as late as 9 hr after virus inoculation prevented approxi- 
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Fro. 6. Effect of IMCBH on the development of total, cell-associated, and released virus 
during  a  single infectious cycle of vaccinia virus  in chick embryo  fibroblasts.  The  input 
multiplicity was 1 PFU/cell. 
mately 99 % of virus release and completely inhibited virus-induced cytopathic 
changes for the duration of a single cycle experiment. When IMCBH was added 
at 12 and 15 hr after virus inoculation, at which times virus releaseproceeded at 
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further release of virus.  Prevention of CPE in these cases was by far not as 
marked as inhibition of virus release. 
The Virus-InkiM~ory  Spectrum of IMCBH.--To  determine the virus-inhibi- 
tory spectrum of IMCBH, the ability of IMCBH to inhibit the multiplication 
of viruses other than vaccinia virus was investigated. Low doses of the viruses 
listed in Table II were inoculated into tube cultures of either chick embryo fibro- 
blasts or monkey kidney cells and the development of virus-induced changes 
was  recorded.  None  of  the  viruses  examined  was  found  to  be  inhibited 
by IMCBH at a concentration of 50/zg/ml. Thus, of all viruses examined so far 
only vaccinia virus was found susceptible to IMCBH. 
Lack of Protecting Effect of IMCBH on Vaccinia  Virus Infection in Mice and 
Rabbits.--To  determine whether IMCBH affects vaccinia virus infections  in 
TABLE  II 
Viruses  Insusceptible  to  [MCBH* 
Cells  Viruses 
Chick embryo fibroblasts 
Monkey kidney cells 
Sindbis virus 
Vesicular stomatitis virus 
Newcastle disease virus (Miyadera) 
Fowl plague virus (Rostock) 
Poliovirus type 1 (Mahoney) 
Echovirus type 12 (Travis) 
Reovirus type 3  (Dearing) 
Adenovirus type 7 
* Dose  of inoculum was  32-320 TCIDs0  per  culture.  Virus  multiplication was  not  in- 
hibited by IMCBH at 50  ~.g/ml. 
vivo, experiments in mice and rabbits were performed. Mice, weighing 16-20 g, 
were inoculated intracerebrally with 50 LD~0 (50 % lethal dose) of vaccinia virus 
(P71). Rabbits were inoculated intracutaneously with 10-1000 LD60 (for mice) 
of the virus. IMCBH was adm{nlstered five times daily subcutaneously or orally 
into mice, and orally into rabbits. Maximum doses of IMCBH per day were 400 
mg/kg body weight for subcutaneous injection into mice, 800 mg/kg for oral 
administration into mice, and 500 mg/kg for oral administration into rabbits. 
The first dose was given 24 hr before virus inoculation. The results of these ex- 
periments indicated that IMCBH exhibits  no protecting effect  on vaccinia 
virus-infected mice and rabbits. 
DISCUSSION 
The inhibitory effect of IMCBH on virus multiplication is characterized  by 
two features, i.e., its virus selectivity and its dependence on certain host cells. 806  INHIBITION  OF  RELEASE  OF  VACCINIA  VIRUS 
IMCBH inhibits only vaccinia virus, but none of a variety of other viruses so 
far tested, and it is nontoxic to cells at virus inhibitory concentrations. How- 
ever, while it was found to inhibit vaccinia virus multiplication in chick embryo 
fibroblasts and monkey kidney cells, it did not do so in L cells. IMCBH did not 
exhibit any protecting effect on vaccinia virus-infected mice and rabbits. Among 
other possibilities, such as insufficient concentrations of compound in the target 
organs, this fact may be due to the dependence of IMCBH action on certain 
host cells. 
The single cycle experiments described indicate that IMCBH, at concentra- 
tions ranging from 3.1  to 50/~g/ml, blocks the release of vaccinia virus from 
chick embryo fibroblasts. It appears that even virus release already under way is 
inhibitable  by IMCBH  (Fig.  7).  I  cannot be  excluded, however,  that  this 
phenomenon is largely due to asynchrony of infection in the cell population. 
Intracellular  multiplication  of  vaccinia  virus  is  only  slightly  inhibited  by 
IMCBH. This finding suggests that the various stages  of virus synthesis, i.e., 
virus adsorption, penetration, uncoating, macromolecular synthesis,  and virus 
assembly remain principally unaffected by IMCBH. IMCBH has no direct in- 
activating effect on the infectivity of vaccinia virus. It can therefore be  con- 
cluded that IMCBH is a selective inhibitor of the release of vaccinia virus. 
IMCBH inhibits markedly the multiplication of vaccinia virus in cultures 
infected at low virus/cell multiplicity. This inhibitory effect is undoubtedly due 
to the protection of a majority of the cells in a culture by the blockade of virus 
release from primarily infected cells. 
As far as we are aware, there are two other reports on inhibition of virus re- 
lease from infected cells. In 1954, Ackermann and Maassab (14,  15) presented 
evidence that a-amino-p-methoxyphenylmethanesulfonic acid interferes with 
the release of influenza virus; this compound also affects an early step in virus 
replication. Becht and Drzeniek (16) recently reported that Congo red inhibits 
the release of fowl plague and Newcastle disease virus, but there is also a marked 
inhibition of the formation of hemagglutinin in cells and consequently of cell- 
associated infective virus. 
It is of considerable interest that in IMCBH-treated cultures no cytopathic 
changes occurred within the span of a single cycle of infection, i.e. 36 hr, whereas 
in untreated control cultures virus-induced cell damage was closely related in 
time to the exponential increase phase of virus multiplication. However, also in 
the treated cultures, extensive cytopathic changes eventually occurred. These 
ultimately developing cytopathic changes were not accompanied by significant 
virus  release. At present,  it cannot he decided whether a  causal relationship 
exists between virus release and virus-induced cell damage. The difficulties arise 
in part from the fact that similar morphologic alterations may be brought about 
by different mechanisms. The following findings (N. Kato and H. J.  Eggers, 
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development of cytopathic effects are causally related: in monkey kidney cell 
cultures infected with vaccinia virus and treated with isatin ~-thiosemicarba- 
zone, virus formation was inhibited, and consequently virus release could not 
occur. Nevertheless, the cytopathic changes in cultures treated with isatin fi- 
thiosemicarbazone were marked, while such changes could hardly be detected in 
cultures treated with IMCBH. 
It has been found in the present study that large inocula of vaccinia virus 
cause early CPE in BHK21 ceils without concommitant virus multiplication. 
Vaccinia virus is known to produce such a toxic CPE in several types of cells 
(8-13).  IMCBH did not inhibit the toxic cytopathic changes induced by vac- 
cinia virus in BHK21 cells. This finding does not necessarily imply that IMCBH 
has no inhibitory effect on the toxic changes, because the inhibitory action of 
IMCBH shows host cell dependence, as described above. The studies should be 
extended to other cells susceptible to the toxic effects of vaccinia virus. 
Further investigations on the precise mechanism of action of IMCBH may 
help to clarify our understanding of the processes involved in release of vaccinia 
virus. 
SUMMARY 
Nrisonicotinoyl-N,-3-methyl-4-chlorobenzoylhydrazine  (IMCBH) is a selec- 
tive inhibitor of vaccinia virus multiplication. In concentrations up to 50 #g/ml, 
IMCBH causes neither toxic morphologic changes, nor does it inhibit the multi- 
plication of cells. Viruses other than vaccinia are not affected by IMCBH. The 
virus-inhibitory effect of IMCBH is dependent on the type of host cell used, i.e., 
the compound is effective in chick embryo fibroblasts and monkey kidney cells 
but not in L  cells.  IMCBH does not exhibit any protecting effect on vaccinia 
virus-infected mice or rabbits. 
IMCBH interferes with virus release: in single cycle experiments in chick 
embryo fibroblasts, IMCBH strongly blocks the release of vaccinia virus at con- 
centrations as low as 3 #g/ml, while intracellular virus synthesis is hardly af- 
fected. Viral cytopathic changes are completely suppressed by IMCBH within 
the span of a single cycle infection, although extensive changes eventually occur. 
By inhibiting virus release from initially infected cells, IMCBH markedly inhi- 
bits the multiplication of vaccinia virus in cell cultures infected at low virus/ 
cell multiplicities. 
IMCBH does not inhibit the early toxic cytopathic changes induced by large 
inocula of vaccinia virus in BHK21 cells. 
We wish to thank Miss Erica Waidner for excellent technical assistance. 
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